Public Markets 3 Hours

Last updated: June 2, 2026, 8:30 PM ET

Equities & IPO Markets

SpaceX is preparing IPO terms as early as Wednesday for what could become the largest-ever listing, while Game Stop shares jumped 13% after-hours following a record quarterly profit driven by collectibles sales rather than its traditional video game business. Ulta Beauty's 11% revenue increase in the fiscal first quarter demonstrated consumer resilience in discretionary spending despite broader economic uncertainty.

Energy & Commodities

Crude oil futures gained modestly as U.S.-Iran peace talks showed signs of stalling, reducing expectations for swift resolution to Middle East supply concerns. Gold prices edged lower near $2,340 per ounce after robust U.S. jobs data reinforced market bets that the Federal Reserve will maintain higher interest rates for longer, reducing the metal's appeal as an inflation hedge.

Fixed Income & Credit Markets

Cliffwater's flagship private credit fund faced 17% redemption requests on net assets of $31 billion, prompting withdrawal limits as retail investors continue exiting the sector amid concerns over credit quality and liquidity. The fund restrictions signal mounting stress in private credit markets that have seen significant outflows this year.

Currency & Central Bank Actions

Taiwan's central bank intensified FX interventions to stamp out currency swings as the artificial intelligence boom creates divergent pressures on the Taiwan dollar, with tech exporters benefiting from AI demand while import costs rise. Commonwealth Bank of Australia warned the Australian dollar could weaken following first-quarter GDP data that may show economic contraction amid China's property crisis.

Political Developments

Acting Attorney General Blanche confirmed the administration would not proceed with Trump's proposed $1.8 billion fund while maintaining an order shielding the president and his family from IRS audits of already-filed returns. Secretary of State Rubio signaled potential U.S. return to the global vaccine program Gavi in pointed congressional testimony, representing a rebuke to Health Secretary Kennedy's previous withdrawal stance.